Daniel Weiss

Daniel Weiss, MD, CPI, currently serves as a Consultant in Drug Development at ECD Life Sciences since December 2023 and holds the position of VP & Head of Early Clinical Development at Schrödinger since March 2021, where successes include establishing a clinical development team and leading multiple successful INDs and first-in-human trials for oncology. Previous roles include Senior Scientific Director at Chugai Pharma USA, where responsibilities encompassed global clinical leadership in oncology and rare diseases, and Medical Director for Clinical Research and Development at Celgene, focusing on pediatric oncology studies. Other notable positions include oversight of Phase I clinical research as a Principal Investigator at Celerion, as well as experience in emergency medicine with Phoenix Physicians and Team Health. Daniel Weiss's educational background includes a Medical Doctor degree from Drexel University College of Medicine, a Master's in Biomedical Sciences from Rutgers, and a Bachelor's in Biology and General Business from James Madison University.